Oramed Pharmaceuticals Inc. — Director's Dealing 2012

Nov 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2007-08-14

Reporting Person: Kidron Miriam (Director, Chief Technology Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-14	Warrant (right to buy)	$0.001	A	3361360	Acquired	2012-08-14	Common Stock (3361360)	Direct
2012-08-08	Warrant (right to buy)	$0.001	D	3361360	Disposed	2012-08-14	Common Stock (3361360)	Direct
2012-08-08	Warrant (right to buy)	$0.001	A	3361360	Acquired	2014-08-06	Common Stock (3361360)	Direct

Footnotes

F1: The warrant was fully vested on the date of issuance.

F2: The two reported transactions involved an amendment of an outstanding warrant to extend the expiration date to August 6, 2014, resulting in the deemed cancellation of the "old" warrant and the grant of a replacement warrant.

F3: The warrant was granted in recognition of Dr. Kidron's contributions to the Issuer in connection with the initial development of its current business.